Skip to content

Efficacy Study of Multiple Micro Nutrients Supplementation

Longitudinal Study on the Effect of Multiple Micro Nutrients Supplementation on Haemoglobin Level of 8 to 22-month-old Indonesian Children.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01840384
Acronym
Babytop
Enrollment
239
Registered
2013-04-25
Start date
2013-07-31
Completion date
2015-03-31
Last updated
2013-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anemia, Iron-deficiency

Keywords

Healthy infants, Anemia, iron-deficiency

Brief summary

This study is initiated to investigate the effect of multi micronutrient supplementation for 12 months on serum haemoglobin level in Indonesian young children.

Interventions

DIETARY_SUPPLEMENTMulti-micronutrients
DIETARY_SUPPLEMENTMaltodextrin and Lactose

Sponsors

PT. Sari Husada
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
8 Months to 10 Months
Healthy volunteers
Yes

Inclusion criteria

* Apparently healthy Indonesian infants * Age 8-10 month at baseline visit * Willing to take 2 sachets of study product per day * Planning to reside in the study area during the next 14-16 months * Written informed consent by parent(s) or legally acceptable representative (in ICF there is statement that both are agree that child participate in the study)

Exclusion criteria

* Haemoglobin \< 8 g/dL at screening visit\*. * Significant congenital abnormality which according to investigator's clinical judgement will interfere the study conduct and assessment * Any known conditions likely to affect nutrient absorption diagnosed by the child's physician * Disorders requiring a special diet (such as food intolerance or food allergy or complaints such as reflux, constipation and cramps for which special formula is required). * Any other current or previous illnesses/conditions or intervention which according to investigator's clinical judgement could interfere the study conduct and assessment (e.g. chronic illness or physical or mental handicaps) * Regular use of MMN supplements syrup (every day in \> 1 week) within two weeks prior to entry into the study. * Not intending to use micronutrient supplements during the study * Participation in any other studies involving similar investigational or marketed products concomitantly or within two weeks prior to entry into the study. * Premature birth (gestational age \<37 weeks) * Low birth weight (\< 2500 g) * Severely under nutrition indicated by any of the following criteria: severely stunted: HAZ \< -3 SD; severely underweight WAZ \<-3 SD; wasted: WHZ \<-2 SD \*Subject with haemoglobin level (finger prick blood sample) at screening visit between 8-10 g/dL will be given iron syrup supplementation for 1 month. Thereafter, haemoglobin level (whole blood sample) will be checked at baseline visit: * If Hb \> 10 g/dL, subject is eligible for randomisation * If Hb \< 10 g/dL, subject is not eligible for randomisation and will be given iron syrup supplementation for 2 months

Design outcomes

Primary

MeasureTime frameDescription
Haemoglobin level12 monthsChange in serum haemoglobin level after 12 months of intervention

Secondary

MeasureTime frameDescription
Anemia prevalence12 monthsChange in anemia prevalence from baseline to after 12 months of intervention
Anthropometric24 months of ageChange in anthropometric measurements from baseline until 24 months of age
Micronutrients12 monthsChange in selected micronutrients status from baseline to after 12 months of intervention

Countries

Indonesia

Contacts

Primary ContactTonny Sundjaya, MD
tonny.sundjaya@danone.com

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026